Treatment Overview
Periurethral Bulking Agent Injection Therapy is a non-surgical, minimally invasive procedure designed to treat stress urinary incontinence (SUI) by improving urethral closure and bladder control. Instead of lifting the bladder mechanically, this treatment works by injecting a bulking material around the urethra to enhance tissue volume and coaptation, allowing better resistance against urine leakage during physical activities.
In Korea, this procedure is performed using advanced endoscopic imaging systems and biocompatible injectable agents such as collagen, hyaluronic acid-based gels, or synthetic microspheres. It is a preferred option for women seeking quick recovery, no incisions, and minimal downtime.
Purpose & Benefits
Purpose:
- To treat stress urinary incontinence caused by urethral weakness or sphincter incompetence.
- To provide additional urethral support by injecting bulking material around the bladder outlet.
- To serve as a safe, non-surgical alternative to sling or bladder lift procedures.
- To restore urinary control and improve quality of life with minimal invasiveness.
Benefits:
- Non-surgical and outpatient-based (procedure completed in 15–30 minutes).
- No need for general anesthesia or hospital stay.
- Immediate improvement in urinary continence for most patients.
- Can be safely repeated if needed for enhanced effect.
- No scarring, minimal discomfort, and quick return to daily life.
- In Korea, performed with endoscopic precision and premium-grade biocompatible materials for durable and natural results.
Ideal Candidates
This therapy is suitable for:
- Women with mild to moderate stress urinary incontinence.
- Patients with urethral sphincter weakness (intrinsic sphincter deficiency).
- Those who cannot undergo major surgery due to health conditions or personal preference.
- Postpartum or menopausal women experiencing urine leakage during exertion.
- Patients seeking non-surgical continence restoration without downtime.
- Individuals with recurrent SUI after prior sling or bladder suspension procedures.
Not suitable for:
- Women with severe prolapse or complete urethral dysfunction.
- Patients with active urinary tract infections or urethral strictures.
Possible Risks & Complications
While safe and effective, potential side effects include:
- Mild burning or discomfort during urination (temporary).
- Slight blood-tinged urine for 24–48 hours.
- Urinary urgency or frequency in early recovery.
- Rare infection at the injection site (minimized with sterile Korean endoscopic techniques).
- Rare overcorrection causing temporary urinary retention.
Korean clinics ensure patient safety using sterile, image-guided injections, high-quality materials, and customized dosing based on urethral anatomy.
Surgical Techniques Used
Korea’s uro-gynecology specialists perform periurethral bulking therapy using ultra-fine endoscopic systems and precision micro-injectors.
Procedure Steps:
- The patient is placed under local anesthesia or light sedation.
- A cystoscope (tiny camera) is inserted through the urethra for visualization.
- Bulking material (collagen, hyaluronic acid, or synthetic microspheres) is injected into the urethral wall at 3–4 evenly spaced sites.
- The bulking agent increases tissue volume, improving urethral closure.
- The patient is observed briefly and discharged within an hour.
Korean Enhancements Include:
- 3D endoscopic imaging for high-definition visualization.
- Adjustable micro-injection depth control for accurate placement.
- Use of long-lasting, FDA-approved bulking agents optimized for Korean patients.
- Combination of pelvic physiotherapy or EMS therapy for sustained results.
- Customized multi-layer injection mapping to tailor urethral support for each patient.
Commonly Used Bulking Agents in Korea:
- Hyaluronic acid-based gels (e.g., NASHA, Macroplastique).
- Calcium hydroxyapatite microspheres (CaHA) for semi-permanent results.
- Collagen and polyacrylamide hydrogels for soft, natural tissue integration.
Recovery & Aftercare
Recovery:
- Same-day discharge; most patients resume normal activities immediately.
- Mild discomfort or light spotting may occur for 24–48 hours.
- Avoid strenuous activity and sexual intercourse for 3–5 days.
Aftercare:
- Drink plenty of fluids to maintain urinary tract health.
- Avoid caffeine, alcohol, and spicy foods for 1–2 days.
- Attend follow-up appointments to assess results and determine if a touch-up injection is needed.
- Follow preventive lifestyle habits (pelvic-floor exercises, bladder training).
- Korean clinics often include pelvic muscle strengthening and EMS therapy post-procedure for enhanced continence.
Results & Longevity
Results:
- Noticeable improvement in urinary control immediately or within days.
- Reduction or complete elimination of leakage during physical activities.
- No scarring or tissue alteration — only volume enhancement of urethral walls.
- Restores confidence and improves daily comfort.
Longevity:
- Results typically last 12–24 months, depending on the agent used and patient factors.
- Some materials (like CaHA) may last up to 3 years or longer.
- Repeat injections can be safely performed to maintain or enhance results.
- In Korea, improved outcomes are achieved by combining bulking therapy with pelvic rehabilitation and advanced imaging follow-ups.
Treatment Process in Korea
Why Korea is a Top Destination:
- Korea is a leading country for non-surgical uro-gynecologic treatments, combining precision technology and biological materials.
- Surgeons are trained in advanced endoscopic injection techniques for urethral restoration.
- Clinics use certified biocompatible agents tailored to patient anatomy and needs.
- Minimal downtime and aesthetic healing make it ideal for busy local and international patients.
- Integrated care model: pre-procedure assessment, image-guided injection, and postoperative monitoring all in one session.
Typical Treatment Process:
- Consultation: Urodynamic testing, ultrasound, and pelvic evaluation.
- Preparation: Local anesthesia or mild sedation.
- Injection: Bulking agent injected into the periurethral tissues via endoscope.
- Observation: Short rest period; patient voids before discharge.
- Follow-Up: Check-ups at 1 week and 1 month to monitor improvement.
Unique Korean Techniques & Technology:
- 3D endoscopic guidance ensuring uniform agent placement.
- Robotic micro-injection systems for ultra-precise delivery.
- Enhanced hydrogel formulations for prolonged tissue integration.
- Hybrid treatments combining bulking injections with HIFU or EMS therapy for muscle reinforcement.
- Painless protocols using micro-needles and localized cooling technology.
Cost Range (Details)
The cost of Periurethral Bulking Agent Injection Therapy in Korea varies by the material used and clinic expertise:
- Standard Hyaluronic Acid Injection: ₩ 2,000,000 – 3,500,000 KRW (≈ US $1,500 – $2,700)
- Calcium Hydroxyapatite (CaHA) or Collagen Injections: ₩ 3,000,000 – 5,000,000 KRW (≈ US $2,300 – $3,800)
- Combination Treatment (Injection + EMS / Laser Therapy): ₩ 5,000,000 – 8,000,000 KRW (≈ US $3,800 – $6,100)
- Comprehensive Pelvic Rehabilitation Package: ₩ 7,000,000 – 10,000,000 KRW (≈ US $5,300 – $7,600)
Korea’s competitive pricing, coupled with advanced medical standards and high patient satisfaction, makes it a top choice for non-surgical bladder suspension alternatives.
Popular Clinics in Korea
- University-affiliated women’s hospitals specializing in non-surgical incontinence treatments.
- Gangnam uro-gynecology centers offering high-precision bulking agent therapies.
- Women-exclusive pelvic health clinics integrating injection therapy with EMS rehabilitation.
- Postpartum recovery centers focusing on pelvic-floor rejuvenation and urinary control.
- International medical centers providing endoscopic incontinence treatment for overseas patients.
